What Happened?
Cambridge, MA-based Omega Therapeutics Appointed Matt Coughlin as Director, Supply Chain
Date of management change: August 28, 2021
Cambridge, MA-based Omega Therapeutics Appointed Matt Coughlin as Director, Supply Chain
Omega Therapeutics is a development-stage biotechnology company pioneering the first systematic approach to use mRNA therapeutics as programmable epigenetic medicines by leveraging its OMEGA Epigenomic Programming™ platform. The OMEGA™ platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism`s life from cell genesis, growth and differentiation to cell death. The OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a normal range without altering native nucleic acid sequences. Omega`s engineered, modular, and programmable mRNA-encoded epigenetic medicines, Omega Epigenomic Controllers™, target specific intervention points amongst the thousands of mapped and validated novel DNA-sequence-based epigenomic loci to durably tune single or multiple genes to treat and cure disease through Precision Genomic Control™. Omega is currently advancing a broad pipeline of development candidates spanning a range of disease areas, including oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.
Matt Coughlin is Director, Supply Chain at Omega Therapeutics. Previously, Matt held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: BIGUET Stéphane, Moriarity Angela, Bothe Sabine, Badarinarayan Harsha, Marshall Amy, Almas Brian, Tauer Kami, Fitzrandolph Laura, Bauer Kelly, Michel Courtney, Bumgarner Ellen
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.